Literature DB >> 19001078

Characterization of Vibrio cholerae outer membrane vesicles as a candidate vaccine for cholera.

Stefan Schild1, Eric J Nelson, Anne L Bishop, Andrew Camilli.   

Abstract

Outer membrane vesicles (OMVs) offer a new approach for an effective cholera vaccine. We recently demonstrated that immunization of female mice with OMVs induces a long-lasting immune response and results in protection of their neonatal offspring from Vibrio cholerae intestinal colonization. This study investigates the induced protective immunity observed after immunization with OMVs in more detail. Analysis of the stomach contents and sera of the neonates revealed significant amounts of anti-OMV immunoglobulins (Igs). Swapping of litters born to immunized and nonvaccinated control mice allowed us to distinguish between prenatal and neonatal uptakes of Igs. Transfer of Igs to neonates via milk was sufficient for complete protection of the neonates from colonization with V. cholerae, while prenatal transfer alone reduced colonization only. Detection of IgA and IgG1 in the fecal pellets of intranasally immunized adult mice indicates an induced immune response at the mucosal surface in the gastrointestinal tract, which is the site of colonization by V. cholerae. When a protocol with three intranasal immunizations 14 days apart was used, the OMVs proved to be efficacious at doses as low as 0.025 microg per immunization. This is almost equivalent to OMV concentrations found naturally in the supernatants of LB-grown cultures of V. cholerae. Heterologous expression of the periplasmic alkaline phosphatase (PhoA) of Escherichia coli resulted in the incorporation of PhoA into OMVs derived from V. cholerae. Intranasal immunization with OMVs loaded with PhoA induced a specific immune response against this heterologous antigen in mice. The detection of an immune response against this heterologously expressed protein is a promising step toward the potential use of OMVs as antigen delivery vehicles in vaccine design.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19001078      PMCID: PMC2612262          DOI: 10.1128/IAI.01139-08

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  63 in total

1.  Global Advisory Committee on Vaccine Safety, 6-7 June 2006.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2006-07-14

2.  Intranasal administration of a meningococcal outer membrane vesicle vaccine induces persistent local mucosal antibodies and serum antibodies with strong bactericidal activity in humans.

Authors:  B Haneberg; R Dalseg; E Wedege; E A Høiby; I L Haugen; F Oftung; S R Andersen; L M Naess; A Aase; T E Michaelsen; J Holst
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

3.  Protective effect on infections with Vibrio cholerae in suckling mice caused by the passive immunization with milk of immune mothers.

Authors:  A Ujiye; K Kobari
Journal:  J Infect Dis       Date:  1970-05       Impact factor: 5.226

4.  An Fc receptor structurally related to MHC class I antigens.

Authors:  N E Simister; K E Mostov
Journal:  Nature       Date:  1989-01-12       Impact factor: 49.962

5.  Use of genetic recombination as a reporter of gene expression.

Authors:  A Camilli; D T Beattie; J J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

6.  Mouse MHC class I-like Fc receptor encoded outside the MHC.

Authors:  J J Ahouse; C L Hagerman; P Mittal; D J Gilbert; N G Copeland; N A Jenkins; N E Simister
Journal:  J Immunol       Date:  1993-12-01       Impact factor: 5.422

7.  Ecology, serology, and enterotoxin production of Vibrio cholerae in Chesapeake Bay.

Authors:  J Kaper; H Lockman; R R Colwell; S W Joseph
Journal:  Appl Environ Microbiol       Date:  1979-01       Impact factor: 4.792

Review 8.  Mucosal immunity.

Authors:  L A Hanson; S Ahlstedt; B Andersson; B Carlsson; M F Cole; J R Cruz; U Dahlgren; T H Ericsson; F Jalil; S R Khan; L Mellander; R Schneerson; C S Edén; T Söderström; C Wadsworth
Journal:  Ann N Y Acad Sci       Date:  1983-06-30       Impact factor: 5.691

9.  Identification of toxS, a regulatory gene whose product enhances toxR-mediated activation of the cholera toxin promoter.

Authors:  V L Miller; V J DiRita; J J Mekalanos
Journal:  J Bacteriol       Date:  1989-03       Impact factor: 3.490

10.  Release of the outer membrane vesicles from Vibrio cholerae and Vibrio parahaemolyticus.

Authors:  K Kondo; A Takade; K Amako
Journal:  Microbiol Immunol       Date:  1993       Impact factor: 1.955

View more
  51 in total

Review 1.  Bacterial outer membrane vesicles in disease and preventive medicine.

Authors:  Can M Unal; Viveka Schaar; Kristian Riesbeck
Journal:  Semin Immunopathol       Date:  2010-12-12       Impact factor: 9.623

2.  Vibrio cholerae-induced inflammation in the neonatal mouse cholera model.

Authors:  Anne L Bishop; Bharathi Patimalla; Andrew Camilli
Journal:  Infect Immun       Date:  2014-03-31       Impact factor: 3.441

3.  A Periplasmic Polymer Curves Vibrio cholerae and Promotes Pathogenesis.

Authors:  Thomas M Bartlett; Benjamin P Bratton; Amit Duvshani; Amanda Miguel; Ying Sheng; Nicholas R Martin; Jeffrey P Nguyen; Alexandre Persat; Samantha M Desmarais; Michael S VanNieuwenhze; Kerwyn Casey Huang; Jun Zhu; Joshua W Shaevitz; Zemer Gitai
Journal:  Cell       Date:  2017-01-12       Impact factor: 41.582

Review 4.  Immune modulation by bacterial outer membrane vesicles.

Authors:  Maria Kaparakis-Liaskos; Richard L Ferrero
Journal:  Nat Rev Immunol       Date:  2015-05-15       Impact factor: 53.106

5.  Mucosal immunization with Vibrio cholerae outer membrane vesicles provides maternal protection mediated by antilipopolysaccharide antibodies that inhibit bacterial motility.

Authors:  Anne L Bishop; Stefan Schild; Bharathi Patimalla; Brian Klein; Andrew Camilli
Journal:  Infect Immun       Date:  2010-08-02       Impact factor: 3.441

6.  Membrane vesicles of Clostridium perfringens type A strains induce innate and adaptive immunity.

Authors:  Yanlong Jiang; Qingke Kong; Kenneth L Roland; Roy Curtiss
Journal:  Int J Med Microbiol       Date:  2014-02-19       Impact factor: 3.473

7.  Proteomics and 1H NMR-based metabolomics analysis of pathogenic Vibrio vulnificus aquacultures isolated from sewage drains.

Authors:  Chundan Zhang; Zhonghua Wang; Dijun Zhang; Jun Zhou; Chenyang Lu; Xiurong Su; Dewen Ding
Journal:  Environ Sci Pollut Res Int       Date:  2017-09-01       Impact factor: 4.223

8.  Outer membrane vesicles derived from Salmonella Typhimurium mutants with truncated LPS induce cross-protective immune responses against infection of Salmonella enterica serovars in the mouse model.

Authors:  Qiong Liu; Qing Liu; Jie Yi; Kang Liang; Tian Liu; Kenneth L Roland; Yanlong Jiang; Qingke Kong
Journal:  Int J Med Microbiol       Date:  2016-08-25       Impact factor: 3.473

9.  Chloroplast-derived vaccine antigens confer dual immunity against cholera and malaria by oral or injectable delivery.

Authors:  Abdoreza Davoodi-Semiromi; Melissa Schreiber; Samson Nalapalli; Dheeraj Verma; Nameirakpam D Singh; Robert K Banks; Debopam Chakrabarti; Henry Daniell
Journal:  Plant Biotechnol J       Date:  2009-12-28       Impact factor: 9.803

10.  Outer membrane vesicles derived from Escherichia coli induce systemic inflammatory response syndrome.

Authors:  Kyong-Su Park; Kyoung-Ho Choi; You-Sun Kim; Bok Sil Hong; Oh Youn Kim; Ji Hyun Kim; Chang Min Yoon; Gou-Young Koh; Yoon-Keun Kim; Yong Song Gho
Journal:  PLoS One       Date:  2010-06-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.